Date published: 2026-5-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

Latrophilin-2 Inhibitors

Latrophilin-2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of Latrophilin-2, a protein encoded by the ADGRL2 gene. Latrophilin-2, also known as adhesion G protein-coupled receptor L2 (ADGRL2), is part of the adhesion GPCR family, which is characterized by its large extracellular region and involvement in cell adhesion and signaling. Latrophilin-2 is notable for its role in cell-cell communication, where it mediates various physiological processes by acting as a receptor that binds to extracellular ligands and transmits signals into the cell through G protein-coupled pathways. This receptor is involved in diverse cellular functions, including neuronal development, synaptic adhesion, and intracellular signaling cascades.

Structurally, Latrophilin-2 inhibitors can encompass a wide range of molecules, including small molecules, peptides, or larger biomolecules engineered to interact specifically with the ligand-binding domains or other critical regions of the Latrophilin-2 protein. These inhibitors typically function by blocking the binding of natural ligands to Latrophilin-2, thereby preventing the receptor from initiating its signaling pathways. By inhibiting Latrophilin-2, these compounds can disrupt the receptor's role in mediating cell adhesion and signaling, leading to alterations in cellular communication and function. The study of Latrophilin-2 inhibitors is crucial for understanding the mechanisms by which adhesion GPCRs regulate cellular processes and the broader implications of their signaling on tissue organization and cellular interactions. Research into these inhibitors provides valuable insights into the complex regulatory networks controlled by Latrophilin-2 and highlights the importance of GPCR-mediated signaling in maintaining cellular homeostasis. By exploring the effects of Latrophilin-2 inhibition, scientists can gain a deeper understanding of the physiological and biochemical pathways influenced by this receptor, revealing its significance in the intricate processes of cellular communication and adhesion.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Clozapine

5786-21-0sc-200402
sc-200402A
sc-200402B
sc-200402C
50 mg
500 mg
5 g
10 g
$69.00
$364.00
$2500.00
$4100.00
11
(1)

Clozapine may inhibit Latrophilin expression by modulating various neurotransmitter receptors and influencing synaptic activities.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

Haloperidol could affect Latrophilin expression by antagonizing dopamine receptors, impacting neural connectivity and signaling.

Olanzapine

132539-06-1sc-212469
100 mg
$133.00
6
(1)

Olanzapine might influence Latrophilin expression by interacting with various neurotransmitter receptors, affecting neural communication.

Risperidone

106266-06-2sc-204881
sc-204881A
sc-204881B
sc-204881C
10 mg
50 mg
1 g
5 g
$174.00
$719.00
$1020.00
$2040.00
1
(1)

Risperidone may affect Latrophilin expression by modulating serotonin and dopamine receptors, influencing neural signaling pathways.

(+)-Bicuculline

485-49-4sc-202498
sc-202498A
50 mg
250 mg
$82.00
$281.00
(1)

Bicuculline might influence Latrophilin expression by antagonizing GABA receptors, impacting inhibitory neurotransmission.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 could inhibit Latrophilin expression by targeting PI3K, affecting intracellular signaling pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 may affect Latrophilin expression by inhibiting MEK, impacting ERK signaling pathways in neurons.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 might inhibit Latrophilin expression by targeting TGF-beta receptors, influencing cellular differentiation and growth.